370 related articles for article (PubMed ID: 27579581)
21. The CanPain SCI Clinical Practice Guidelines for Rehabilitation Management of Neuropathic Pain after Spinal Cord: introduction, methodology and recommendation overview.
Loh E; Guy SD; Mehta S; Moulin DE; Bryce TN; Middleton JW; Siddall PJ; Hitzig SL; Widerström-Noga E; Finnerup NB; Kras-Dupuis A; Casalino A; Craven BC; Lau B; Côté I; Harvey D; O'Connell C; Orenczuk S; Parrent AG; Potter P; Short C; Teasell R; Townson A; Truchon C; Bradbury CL; Wolfe D
Spinal Cord; 2016 Aug; 54 Suppl 1():S1-6. PubMed ID: 27444714
[TBL] [Abstract][Full Text] [Related]
22. Considerations in the Management of Upper Extremity Spasticity.
Gart MS; Adkinson JM
Hand Clin; 2018 Nov; 34(4):465-471. PubMed ID: 30286961
[TBL] [Abstract][Full Text] [Related]
23. The CanPain SCI Clinical Practice Guidelines for Rehabilitation Management of Neuropathic Pain after Spinal Cord: screening and diagnosis recommendations.
Mehta S; Guy SD; Bryce TN; Craven BC; Finnerup NB; Hitzig SL; Orenczuk S; Siddall PJ; Widerström-Noga E; Casalino A; Côté I; Harvey D; Kras-Dupuis A; Lau B; Middleton JW; Moulin DE; O'Connell C; Parrent AG; Potter P; Short C; Teasell R; Townson A; Truchon C; Wolfe D; Bradbury CL; Loh E
Spinal Cord; 2016 Aug; 54 Suppl 1():S7-S13. PubMed ID: 27444717
[TBL] [Abstract][Full Text] [Related]
24. Botulinum Toxin: From Poison to Possible Treatment for Spasticity in Spinal Cord Injury.
Palazón-García R; Benavente-Valdepeñas AM
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063051
[TBL] [Abstract][Full Text] [Related]
25. Living with chronic neuropathic pain after spinal cord injury: an interpretative phenomenological analysis of community experience.
Hearn JH; Cotter I; Fine P; A Finlay K
Disabil Rehabil; 2015; 37(23):2203-11. PubMed ID: 25601144
[TBL] [Abstract][Full Text] [Related]
26. Neuropathic pain following spinal cord injury: what we know about mechanisms, assessment and management.
D'Angelo R; Morreale A; Donadio V; Boriani S; Maraldi N; Plazzi G; Liguori R
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(23):3257-61. PubMed ID: 24338470
[TBL] [Abstract][Full Text] [Related]
27. Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders.
Yablon SA
Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):833-74, vii-viii. PubMed ID: 11723867
[TBL] [Abstract][Full Text] [Related]
28. Neuropathic pain and SCI: Identification and treatment strategies in the 21st century.
Hatch MN; Cushing TR; Carlson GD; Chang EY
J Neurol Sci; 2018 Jan; 384():75-83. PubMed ID: 29249383
[TBL] [Abstract][Full Text] [Related]
29. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury.
Kamen L; Henney HR; Runyan JD
Curr Med Res Opin; 2008 Feb; 24(2):425-39. PubMed ID: 18167175
[TBL] [Abstract][Full Text] [Related]
30. The CanPain SCI Clinical Practice Guideline for Rehabilitation Management of Neuropathic Pain after Spinal Cord: recommendations for model systems of care.
Guy SD; Mehta S; Harvey D; Lau B; Middleton JW; O'Connell C; Townson A; Truchon C; Wolfe D; Bradbury CL; Bryce TN; Casalino A; Côté I; Craven BC; Finnerup NB; Hitzig SL; Kras-Dupuis A; Moulin DE; Orenczuk S; Parrent AG; Potter P; Siddall PJ; Short C; Teasell R; Widerström-Noga E; Loh E
Spinal Cord; 2016 Aug; 54 Suppl 1():S24-7. PubMed ID: 27444716
[TBL] [Abstract][Full Text] [Related]
31. Successful Treatment of Central Pain and Spasticity in Patient With Multiple Sclerosis With Dorsal Column, Paresthesia-Free Spinal Cord Stimulator: A Case Report.
Lam CM; Monroe BR
A A Pract; 2019 May; 12(9):308-312. PubMed ID: 31048600
[TBL] [Abstract][Full Text] [Related]
32. Spasticity increases during pregabalin withdrawal.
Braid JJ; Kirker SG; Baguley IJ
Brain Inj; 2013; 27(1):120-4. PubMed ID: 23252443
[TBL] [Abstract][Full Text] [Related]
33. Transcranial Direct Current Stimulation and Visual Illusion Effect According to Sensory Phenotypes in Patients With Spinal Cord Injury and Neuropathic Pain.
Soler D; Moriña D; Kumru H; Vidal J; Navarro X
J Pain; 2021 Jan; 22(1):86-96. PubMed ID: 32629032
[TBL] [Abstract][Full Text] [Related]
34. Quality of life after spinal cord injury: The impact of pain.
Burke D; Lennon O; Fullen BM
Eur J Pain; 2018 Oct; 22(9):1662-1672. PubMed ID: 29770520
[TBL] [Abstract][Full Text] [Related]
35. Chronic neuropathic pain in SCI: evaluation and treatment.
Felix ER
Phys Med Rehabil Clin N Am; 2014 Aug; 25(3):545-71, viii. PubMed ID: 25064788
[TBL] [Abstract][Full Text] [Related]
36. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
37. Management of spasticity after spinal cord injury: current techniques and future directions.
Elbasiouny SM; Moroz D; Bakr MM; Mushahwar VK
Neurorehabil Neural Repair; 2010 Jan; 24(1):23-33. PubMed ID: 19723923
[TBL] [Abstract][Full Text] [Related]
38. Spinal cord injury pain.
Saulino M
Phys Med Rehabil Clin N Am; 2014 May; 25(2):397-410. PubMed ID: 24787340
[TBL] [Abstract][Full Text] [Related]
39. Central pain syndromes.
Hassaballa D; Harvey RL
NeuroRehabilitation; 2020; 47(3):285-297. PubMed ID: 32986620
[TBL] [Abstract][Full Text] [Related]
40. Pain, spasticity and quality of life in individuals with traumatic spinal cord injury in Denmark.
Andresen SR; Biering-Sørensen F; Hagen EM; Nielsen JF; Bach FW; Finnerup NB
Spinal Cord; 2016 Nov; 54(11):973-979. PubMed ID: 27067654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
